Suppr超能文献

贝替欧因对人牙周膜细胞炎症介质和抗氧化酶表达的影响。

The effects of berteroin on inflammatory mediators and antioxidant enzymes expression in human periodontal ligament cells.

机构信息

Department of Regenerative Dental Medicine, Institute Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto-Cho, Tokushima, Tokushima, 770-8504, Japan.

Department of Oral Health Care Promotion, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Tokushima, Japan.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2233-2240. doi: 10.1007/s00210-023-02761-6. Epub 2023 Oct 7.

Abstract

Berteroin is a bioactive substance classified as an isothiocyanate found in cruciferous vegetables such as cabbage, arugula, and salad leaves. In this study, we aimed to determine whether berteroin exerts anti-inflammatory effects on human periodontal ligament cells (HPDLCs), a resident cells of periodontal tissue. Berteroin suppressed interleukin (IL)-1β or tumor necrosis factor (TNF)-α-induced chemokines (C-C motif chemokine ligand (CCL)2, CCL20, C-X-C motif chemokine ligand (CXCL)10, IL-8, and IL-6) production and intercellular adhesion molecule (ICAM)-1 expression in HPDLCs. In addition, berteroin inhibited phosphorylation of IκB kinase (IKK)- α/ β, nuclear factor (NF)- κB p65, and IκB- α and degradation of IκB- α in the NF-κB pathway induced by IL-1 β or TNF- α stimulation. Moreover, berteroin could inhibit signal transducer and activator of transcription (STAT)3 phosphorylation in TNF- α -stimulated HPDLC. Furthermore, berteroin increased the expression of the antioxidant enzymes, heme oxygenase (HO)-1 and NAD(P)H quinone dehydrogenase (NQO)1, in IL-1 β or TNF- α -stimulated HPDLCs. These results suggest that berteroin may decrease the production of inflammatory mediators in HPDLCs by suppressing the NF-κB pathway, and may also decrease the local reactive oxygen species (ROS) production in periodontal lesions by increasing the production of antioxidant enzymes.

摘要

伯替醇是一种生物活性物质,属于异硫氰酸盐,存在于十字花科蔬菜中,如卷心菜、芝麻菜和沙拉叶。在这项研究中,我们旨在确定伯替醇是否对人牙周韧带细胞(HPDLCs)发挥抗炎作用,HPDLCs 是牙周组织的常驻细胞。伯替醇抑制白细胞介素(IL)-1β 或肿瘤坏死因子(TNF)-α 诱导的趋化因子(C-C 基序趋化因子配体(CCL)2、CCL20、C-X-C 基序趋化因子配体(CXCL)10、IL-8 和 IL-6)的产生和细胞间黏附分子(ICAM)-1 在 HPDLCs 中的表达。此外,伯替醇抑制 IκB 激酶(IKK)-α/β、核因子(NF)-κB p65 和 IκB-α 在 IL-1β 或 TNF-α 刺激诱导的 NF-κB 通路中的磷酸化和 IκB-α 的降解。此外,伯替醇可抑制 TNF-α 刺激的 HPDLC 中信号转导和转录激活因子(STAT)3 的磷酸化。此外,伯替醇增加了抗氧化酶血红素加氧酶(HO)-1 和 NAD(P)H 醌氧化还原酶(NQO)1 在 IL-1β 或 TNF-α 刺激的 HPDLCs 中的表达。这些结果表明,伯替醇可能通过抑制 NF-κB 通路减少 HPDLCs 中炎症介质的产生,并通过增加抗氧化酶的产生减少牙周病变中局部活性氧(ROS)的产生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验